At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02480 LUZHU BIOTECH-B
Closed The first weekday after Christmas Day 12-24 11:04:02
23.600
+0.240
+1.03%
High23.400
Low23.400
Vol600.00
Open23.400
D1 Closing23.360
Amplitude0.00%
Mkt Cap4.70B
Tradable Cap4.70B
Total Shares199.00M
T/O14.04K
T/O Rate0.00%
Tradable Shares199.00M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Beijing Luzhu (02480) Announces Monthly Return on Securities Movements for November 2025
Beijing Luzhu Biotechnology Co Ltd is a China-based company primarily engaged in the research, development and production of vaccines and therapeutic biologics. The Company is also engaged in the development of innovative human vaccines and therapeutic biologics to prevent and control infectious diseases and treat cancer and autoimmune diseases. The Company's products include clinical-stage product candidates and pre-clinical-stage product candidates. The core product LZ901 is mainly used to prevent shingles caused by the varicella-zoster virus in adults aged 50 years and above. The Company mainly conducts its businesses in the domestic market.